US Market News
1週前
Ecolab Schedules Webcast of Industry Conference for June 2, 2026May 27, 2026 4:15 PM
Business Wire Scott Kirkland, CFO, will address financial analysts at the William Blair Annual Growth Stock Conference on Tuesday June 2, 2026. Ecolab will offer a webcast of Mr. Kirkland’s presentation. Details for the webcast are as follows: TIME: 10:00am CT DATE: June 2, 2026 DURATION: Approximately 30 minutes LOCATION: www.ecolab.com/investor ARCHIVE: A replay of the webcast will be available through September 2, 2026. To access the webcast, visit the Events & Presentations section of Ecolab’s Investor website at www.ecolab.com/investor and click on the webcast details. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science-based solutions, data driven insights, AI technology and world-class service. This unique combination enables Ecolab to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, Ecolab delivers $16 billion in annual sales, employs 48,000 associates and serves customers in more than 170 countries and 40 industries. The company helps protect one-third of the world’s food production and a quarter of the power generated while delivering innovative solutions across food, hospitality, healthcare, data centers, microelectronics and life sciences. As the world’s water company, Ecolab plays an important role in AI growth by supporting the full water needs of advanced computing—from ultra pure water for chip manufacturing, to water solutions that support the power behind AI, to direct liquid cooling systems for high density computing that improves performance while reducing environmental impact through circular water use. In life sciences, Ecolab delivers end to end solutions that support the development and manufacturing of life-saving drugs, helping customers operate safely and consistently at scale while improving performance and reducing environmental impact. Through its comprehensive approach, Ecolab protects what’s vital, with a goal by 2030 to help protect 2 billion people from infections and conserve enough drinking water for 1 billion people, while continuing to enhance business performance. www.ecolab.com Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab. (ECL-C) View source version on businesswire.com: https://www.businesswire.com/news/home/20260527396708/en/ Investor Contacts:
Andrew Hedberg
+1 651 250 2185 Original: Ecolab Schedules Webcast of Industry Conference for June 2, 2026
US Market News
4週前
Ecolab Declares Cash DividendMay 7, 2026 1:44 PM
Business Wire The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.73 per common share, to be paid July 15, 2026, to shareholders of record at the close of business on June 16, 2026. Ecolab has paid cash dividends on its common stock for 89 consecutive years. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science-based solutions, data driven insights, AI technology and world-class service. This unique combination enables Ecolab to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, Ecolab delivers $16 billion in annual sales, employs 48,000 associates and serves customers in more than 170 countries and 40 industries. The company helps protect one-third of the world’s food production and a quarter of the power generated while delivering innovative solutions across food, hospitality, healthcare, data centers, microelectronics and life sciences. As the world’s water company, Ecolab plays an important role in AI growth by supporting the full water needs of advanced computing—from ultra pure water for chip manufacturing, to water solutions that support the power behind AI, to direct liquid cooling systems for high density computing that improves performance while reducing environmental impact through circular water use. In life sciences, Ecolab delivers end to end solutions that support the development and manufacturing of life-saving drugs, helping customers operate safely and consistently at scale while improving performance and reducing environmental impact. Through its comprehensive approach, Ecolab protects what’s vital, with a goal by 2030 to help protect 2 billion people from infections and conserve enough drinking water for 1 billion people, while continuing to enhance business performance. Ecolab. Protecting What’s Vital. www.ecolab.com (ECL-D) View source version on businesswire.com: https://www.businesswire.com/news/home/20260506712506/en/ Investor Contacts: Andrew C. Hedberg
651.250.2185 Andrew Pearson
651.250.3654 Original: Ecolab Declares Cash Dividend
US Market News
1月前
Ecolab Life Sciences erweitert seine weltweiten Kapazitäten im Bereich Bioprozesstechnik mit einem neuen Zentrum für fortgeschrittene Entwicklung und Anwendungen in KoreaApril 30, 2026 12:05 PM
Business Wire
Die neue Niederlassung bringt den Kunden in Asien fundiertes Fachwissen näher und stärkt das globale Netzwerk von Ecolab
Aufbauend auf dem anhaltenden Wachstum und der starken Leistung seines Life-Sciences-Geschäfts baut Ecolab seine globalen Kompetenzen im Bereich der Bioverarbeitung weiter aus, um biopharmazeutische Hersteller weltweit zu unterstützen. Ecolab Life Sciences gab heute die Eröffnung eines neuen Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, bekannt – seiner ersten biotechnischen Anlage in Asien. Das neue Zentrum stärkt die weltweite Präsenz des Unternehmens im Bereich Life Sciences weiter und unterstützt Kunden, die auf einem der weltweit fortschrittlichsten Märkte für die biopharmazeutische Produktion tätig sind.
BPAL Korea unterstützt das gesamte Spektrum der Prozessentwicklungsaktivitäten, von Tests in der Frühphase bis hin zu Studien, die die Produktion im industriellen Maßstab nachbilden, und stützt sich dabei auf das etablierte Netzwerk von Ecolab für biotechnische Anwendungen in den USA und Großbritannien. Die Einrichtung ermöglicht eine enge Zusammenarbeit mit den Fachleuten für biologische Verfahren von Ecolab, um Kunden dabei zu unterstützen, ihre Reinigungsverfahren zu optimieren, die Kosten- und Prozesseffizienz zu steigern und ihre Programme bis zur Marktreife voranzutreiben.
Korea hat sich zu einem globalen Zentrum für die Herstellung von Biopharmazeutika entwickelt, insbesondere von Biosimilars, die weltweit den Zugang zu fortschrittlichen Therapien verbessern. In diesem von starkem Wettbewerb geprägten Umfeld müssen Hersteller Schnelligkeit, technische Präzision und die Einhaltung globaler Standards gewährleisten. Da nun Experten für Bioverarbeitung vor Ort tätig sind, können Kunden ihre Entwicklung effizienter vorantreiben, indem sie den Materialtransfer ins Ausland vermeiden und gleichzeitig die Konsistenz und Kosteneffizienz ihrer weltweiten Aktivitäten aufrechterhalten.
„Biopharmazeutische Hersteller in ganz Asien stehen unter zunehmendem Druck, schnell zu expandieren und gleichzeitig strenge regulatorische und leistungsbezogene Anforderungen zu erfüllen“, sagte Jenny Tan, Vizepräsidentin und Geschäftsführerin von Ecolab Life Sciences für den asiatisch-pazifischen Raum und Indien. „BPAL Korea stärkt unsere Fähigkeit, eng mit unseren Kunden zusammenzuarbeiten, indem es fundiertes lokales Fachwissen mit dem globalen, integrierten Netzwerk von Ecolab im Bereich der biologischen Verfahrenstechnik verbindet.“
BPAL Korea ist das jüngste Beispiel für das langfristige Engagement von Ecolab Life Sciences in der Life-Sciences-Branche und baut auf den kontinuierlichen Innovationen im gesamten Bioprozess-Portfolio des Unternehmens auf, einschließlich seiner Affinitätsharz-Technologien. Durch den Ausbau seines weltweiten Netzwerks von Entwicklungs- und Anwendungszentren unterstützt Ecolab Life Sciences seine Kunden dabei, ihr Wachstum voranzutreiben und fortschrittliche Therapien weltweit schnell, zuverlässig und sicher zu skalieren.
Wenn Sie mehr über die Kompetenzen von Ecolab Life Sciences bei der Entwicklung der Biotechnologie erfahren möchten und darüber, wie BPAL Korea skalierbare, behördlich zugelassene Aufreinigungsprozesse unterstützt, besuchen Sie hier die Website von Ecolab zu den Purolite™-Harzen.
Über Ecolab
Als vertrauenswürdiger Partner für Millionen von Kunden ist Ecolab (NYSE:ECL) ein weltweit führender Anbieter von Lösungen und Dienstleistungen in den Bereichen Wasser, Hygiene und Infektionsprävention, die zum Schutz von Menschen und lebenswichtigen Ressourcen dienen. Seit mehr als einem Jahrhundert treibt Ecolab Innovationen voran, indem es wissenschaftlich fundierte Lösungen, datengestützte Erkenntnisse, KI-Technologie und erstklassigen Service miteinander verbindet. Dank dieser einzigartigen Kombination kann Ecolab gemeinsam mit seinen Kunden den Maßstab für Spitzenleistungen setzen, und diese in ihren gesamten Betriebsabläufen umsetzen, um ihnen zu Höchstleistungen zu verhelfen. Heute erzielt Ecolab einen Jahresumsatz von 16 Milliarden US-Dollar, beschäftigt 48.000 Mitarbeiter und bedient Kunden in mehr als 170 Ländern und 40 Branchen. Das Unternehmen trägt dazu bei, ein Drittel der weltweiten Nahrungsmittelproduktion und ein Viertel der erzeugten Energie zu schützen, und bietet gleichzeitig innovative Lösungen für die Bereiche Lebensmittel, Gastgewerbe, Gesundheitswesen, Rechenzentren, Mikroelektronik und Biowissenschaften. Als weltweit führendes Wasserunternehmen spielt Ecolab eine wichtige Rolle beim Wachstum der KI, indem es den gesamten Wasserbedarf für moderne Rechenanwendungen abdeckt – von ultrareinem Wasser für die Chipherstellung über Wasserlösungen zur Unterstützung der Leistungsfähigkeit der KI bis hin zu direkten Flüssigkeitskühlsystemen für Rechenanwendungen mit hoher Dichte, um die Leistungsfähigkeit zu erhöhen und gleichzeitig die Umweltbelastung durch eine zirkuläre Wassernutzung zu verringern. Im Bereich der Biowissenschaften bietet Ecolab ganzheitliche Lösungen, die die Entwicklung und Herstellung lebensrettender Medikamente unterstützen. Damit hilft das Unternehmen seinen Kunden, sicher und konsistent in großem Maßstab zu arbeiten, ihre Leistung zu steigern und gleichzeitig die Umweltbelastung zu minimieren. Mit seinem ganzheitlichen Ansatz schützt Ecolab das, was wirklich zählt: Bis 2030 will das Unternehmen dazu beitragen, 2 Milliarden Menschen vor Infektionen zu schützen und genügend Trinkwasser für 1 Milliarde Menschen zu sichern – und dabei gleichzeitig die Unternehmensleistung weiter zu steigern.
Ecolab – wir schützen das, was wirklich zählt.
www.ecolab.com
Folgen Sie uns auf @Ecolab, Instagram @Ecolab_Inc und Facebook @Ecolab.
(ECL-C)
Die Ausgangssprache, in der der Originaltext veröffentlicht wird, ist die offizielle und autorisierte Version. Übersetzungen werden zur besseren Verständigung mitgeliefert. Nur die Sprachversion, die im Original veröffentlicht wurde, ist rechtsgültig. Gleichen Sie deshalb Übersetzungen mit der originalen Sprachversion der Veröffentlichung ab.
Originalversion auf businesswire.com ansehen: https://www.businesswire.com/news/home/20260428185090/de/
Joseph Durrant
651-250-4724
MediaRelations@Ecolab.com
Original: Ecolab Life Sciences erweitert seine weltweiten Kapazitäten im Bereich Bioprozesstechnik mit einem neuen Zentrum für fortgeschrittene Entwicklung und Anwendungen in Korea
US Market News
1月前
Ecolab Life Sciences renforce ses capacités mondiales en bioprocédés grâce à un nouveau pôle de développement et d'applications ultra-moderne, en CoréeApril 30, 2026 12:04 PM
Business Wire
Ce nouveau site offre une expertise approfondie aux clients asiatiques et renforce le réseau mondial d'Ecolab
S’appuyant sur la croissance continue et les solides performances de son secteur en sciences de la vie, Ecolab élargit encore ses capacités mondiales en matière de bioprocédés afin d'accompagner les fabricants biopharmaceutiques du monde entier. Ecolab Life Sciences a annoncé aujourd'hui l'ouverture d'un nouveau laboratoire d'applications de bioprocédés (BPAL) à Dongtan, en Corée, inaugurant ainsi son premier site de bioprocédés en Asie. Ce nouveau pôle renforce la présence mondiale de l'entreprise dans le domaine des sciences de la vie et accompagne ses clients opérant sur l'un des marchés de fabrication biopharmaceutique les plus avancés au monde.
Le laboratoire BPAL Korea prend en charge l'ensemble des activités de développement de procédés, depuis les essais préliminaires jusqu'aux études reproduisant la production à grande échelle, en s'appuyant sur le réseau d'applications de bioprocédés d'Ecolab bien implanté aux États-Unis et au Royaume-Uni. Ce laboratoire permet une collaboration directe avec les experts en bioprocédés d'Ecolab afin d'aider les clients à optimiser leurs procédés de purification, à améliorer leur rentabilité et leur efficacité, et à faire progresser leurs programmes vers la commercialisation.
La Corée s'est imposée comme un pôle mondial de production biopharmaceutique, notamment pour les biosimilaires qui élargissent l'accès aux thérapies innovantes à l'échelle internationale. Dans ce contexte extrêmement concurrentiel, les fabricants doivent faire preuve de rapidité, de rigueur technique et de conformité aux normes internationales. Grâce à la présence locale d'experts en bioprocédés, les clients peuvent accélérer leurs développements plus efficacement en évitant les transferts de matières premières à l'étranger, tout en garantissant la cohérence et la maîtrise des coûts de leurs activités mondiales.
« Les fabricants biopharmaceutiques en Asie subissent une pression croissante pour augmenter rapidement leur production tout en répondant à des exigences réglementaires et de performance élevées », a déclaré Jenny Tan, vice-présidente et general manager d'Ecolab Life Sciences pour la région Asie-Pacifique et l'Inde. « L'acquisition de BPAL Korea renforce notre capacité à travailler en étroite collaboration avec nos clients, en associant une expertise locale approfondie au réseau mondial et intégré de bioprocédés d'Ecolab. »
BPAL Korea est le dernier exemple en date de l’investissement à long terme d’Ecolab Life Sciences dans le secteur des sciences de la vie, s’appuyant sur l’innovation continue dans son portefeuille de bioprocédés, notamment ses technologies de résines d’affinité. En développant son réseau mondial de pôles de développement et d’applications, Ecolab Life Sciences aide ses clients à optimiser leur croissance et à déployer des thérapies de pointe de manière rapide, fiable et en toute confiance à l’échelle internationale.
Pour en savoir plus sur les capacités de développement de bioprocédés d'Ecolab Life Sciences et sur la manière dont BPAL Korea accompagne les procédés de purification évolutifs et conformes aux réglementations, consultez le site web des résines Purolite™ d'Ecolab en cliquant ici.
À propos d'Ecolab
Partenaire de confiance de millions de clients, Ecolab (NYSE : ECL) est un leader mondial des solutions et services en matière de traitement de l’eau, d’hygiène et de prévention des infections qui protègent les personnes et les ressources vitales. Depuis plus d’un siècle, Ecolab favorise l’innovation en intégrant des solutions scientifiques, des analyses de données, l’intelligence artificielle et un service d’excellence. Cette combinaison unique permet à Ecolab d’accompagner ses clients dans la définition des meilleures pratiques et leur déploiement à l’échelle de leurs activités, les aidant ainsi à atteindre des performances optimales. Aujourd'hui, Ecolab réalise un chiffre d'affaires annuel de 16 milliards de dollars, emploie 48 000 collaborateurs et sert des clients dans plus de 170 pays et 40 secteurs d'activité. L'entreprise contribue à protéger un tiers de la production alimentaire mondiale et un quart de l'électricité produite, tout en proposant des solutions innovantes dans les domaines de l'agroalimentaire, de l'hôtellerie, de la santé, des data centers, de la microélectronique et des sciences de la vie. En tant que leader mondial dans le domaine de l'eau, Ecolab joue un rôle important dans la croissance de l'IA en répondant à tous les besoins en eau de l'informatique de pointe : de l'eau ultra-pure pour la fabrication de puces aux solutions d'eau qui alimentent la puissance de l'IA, en passant par les systèmes de refroidissement par liquide direct pour l'informatique haute densité qui améliorent les performances tout en réduisant l'impact environnemental grâce à une utilisation circulaire de l'eau. Dans le domaine des sciences de la vie, Ecolab propose des solutions complètes pour le développement et la fabrication de médicaments vitaux, permettant à ses clients d'opérer en toute sécurité et de manière constante à grande échelle, tout en améliorant leurs performances et en réduisant leur impact environnemental. Grâce à son approche globale, Ecolab protège ce qui est vital, avec pour objectif, d'ici 2030, de contribuer à protéger 2 milliards de personnes contre les infections et de préserver les ressources en eau potable pour 1 milliard de personnes, tout en continuant d'améliorer ses performances commerciales.
Ecolab. Protéger ce qui est vital.
www.ecolab.com
Suivez-nous sur LinkedIn @Ecolab, Instagram @Ecolab_Inc et Facebook @Ecolab.
(ECL-C)
Le texte du communiqué issu d’une traduction ne doit d’aucune manière être considéré comme officiel. La seule version du communiqué qui fasse foi est celle du communiqué dans sa langue d’origine. La traduction devra toujours être confrontée au texte source, qui fera jurisprudence.
Consultez la version source sur businesswire.com : https://www.businesswire.com/news/home/20260428992044/fr/
Joseph Durrant
651-250-4724
MediaRelations@Ecolab.com
Original: Ecolab Life Sciences renforce ses capacités mondiales en bioprocédés grâce à un nouveau pôle de développement et d'applications ultra-moderne, en Corée
US Market News
1月前
Ecolab to Webcast Annual Meeting on May 7, 2026April 29, 2026 5:00 PM
Business Wire
Ecolab will host a live webcast of its annual meeting of stockholders. As indicated in our proxy statement, the 2026 Annual Meeting of Stockholders will be a virtual-only meeting.
Details for the public webcast are as follows:
TIME:
9:30 a.m. Central Time
DATE:
Thursday, May 7, 2026
DURATION:
Approximately 30 minutes
LOCATION:
www.virtualshareholdermeeting.com/ECL2026
ARCHIVE:
A replay of the webcast will be available 24 hours after the end of the meeting
To be admitted to the Annual Meeting at www.virtualshareholdermeeting.com/ECL2026, and to participate and ask questions during the meeting, a stockholder must enter the 16-digit control number found on the proxy card, voting instruction form or notice of internet availability previously mailed or made available to stockholders.
Stockholders and other interested parties may also register as guests in listen only mode without the 16-digit control number.
Online access to the audio webcast will open 15 minutes prior to the start of the 2026 Annual Meeting.
About Ecolab
A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science-based solutions, data driven insights, AI technology and world-class service. This unique combination enables Ecolab to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, Ecolab delivers $16 billion in annual sales, employs 48,000 associates and serves customers in more than 170 countries and 40 industries. The company helps protect one-third of the world’s food production and a quarter of the power generated while delivering innovative solutions across food, hospitality, healthcare, data centers, microelectronics and life sciences. As the world’s water company, Ecolab plays an important role in AI growth by supporting the full water needs of advanced computing—from ultra pure water for chip manufacturing, to water solutions that support the power behind AI, to direct liquid cooling systems for high density computing that improves performance while reducing environmental impact through circular water use. In life sciences, Ecolab delivers end to end solutions that support the development and manufacturing of life-saving drugs, helping customers operate safely and consistently at scale while improving performance and reducing environmental impact. Through its comprehensive approach, Ecolab 8 protects what’s vital, with a goal by 2030 to help protect 2 billion people from infections and conserve enough drinking water for 1 billion people, while continuing to enhance business performance.
Ecolab. Protecting What’s Vital.
www.ecolab.com
(ECL-C)
View source version on businesswire.com: https://www.businesswire.com/news/home/20260429419671/en/
Investor Contacts:
Andrew C. Hedberg
651.250.2185
Andrew Pearson
651.250.3654
Original: Ecolab to Webcast Annual Meeting on May 7, 2026
US Market News
3月前
Ecolab to Acquire CoolIT Systems, a Global Leader in Advanced Liquid Cooling for Next-Gen AI Data CentersMarch 20, 2026 8:00 AM
Business Wire
Acquisition accelerates Ecolab’s sales growth by significantly expanding its Global High-Tech growth engine, creating an end-to-end fluid management and cooling platform for AI data centers
Ecolab announced today that it has entered into a definitive agreement to acquire CoolIT Systems, a high-growth, high-margin leader in liquid cooling technology for next-gen AI data centers. CoolIT is expected to generate approximately $550 million in sales over the next 12 months. With CoolIT’s rapid sales growth, the acquisition is expected to significantly strengthen the company’s Global High-Tech growth engine and accelerate Global Water’s organic sales growth rate by 2% and Ecolab’s total organic sales growth rate by 1%. The acquisition, from funds managed by KKR, positions Ecolab as a comprehensive cooling solutions provider by advancing its capabilities across the rapidly growing data center market.
CoolIT is a pure-play data center liquid cooling company with end-to-end capabilities that designs and manufactures high-performance liquid cooling systems, including coolant distribution units (CDUs), cold plates and direct-to-chip cooling technologies. With more than 25 years of experience, their technology helps the world’s largest hyperscale and colocation operators run more efficiently and reliably. As data centers shift from air cooling to liquid cooling to support rising compute demands, CoolIT’s mission-critical technologies provide the performance needed for advanced AI workloads.
By combining CoolIT’s anchor thermal engineering technologies and design excellence with Ecolab’s expertise in water, chemistry, fluid management, digital monitoring and global service, Ecolab is bolstering its Cooling-as-a-Service offering. This integrated solution helps AI data centers improve performance, reduce downtime and lower water use across their operations.
Under the terms of the agreement, Ecolab will pay approximately $4.75 billion in cash at the closing of the transaction, subject to customary adjustments. This represents 29x and 24x estimated next 12-month and 2027 adjusted EBITDA for CoolIT.
“AI is transforming the demands on data centers, and liquid cooling is one of the critical technologies that makes advanced computing possible,” said Christophe Beck, Ecolab chairman and chief executive officer. “By bringing together CoolIT’s engineered cooling technologies with Ecolab’s expertise in water, chemistry and digital service, we can provide our customers a complete cooling solution that improves performance and reliability while reducing water and energy use. This acquisition expands our role in serving the AI ecosystem—semiconductor fabs that manufacture chips, power plants that fuel the chips, and data centers that utilize the chips—and positions Ecolab as the partner that the world’s largest technology companies rely on to grow responsibly and sustainably.”
Strategic Highlights
CoolIT is a high-growth, high-margin global leader in advanced liquid cooling technologies with 100% focus on the data center market. The acquisition enables Ecolab to rapidly accelerate its recurring, high-margin data center cooling business, by adding mission-critical anchor technologies including CDUs, cold plates, liquid loops and rack manifolds, with substantial cross-selling opportunities.
CoolIT will double Ecolab’s Global High-Tech market opportunity from $5 billion to $10 billion, with this market growing strong double-digits annually. The combination complements Ecolab’s existing reach across more than 1,000 data centers by providing deep preexisting relationships with the world’s major hyperscaler and colocation customers, with strong revenue growth visibility from large-scale data center deployments. CoolIT also contributes advanced engineering, design and validation capabilities, highlighted by custom-designed solutions for leading AI chip developers, including NVIDIA and AMD, along with manufacturing and supply chain expertise to support rapid scaling.
Financial Highlights
The acquisition is expected to be accretive to Ecolab’s sales growth, accelerating Global Water’s organic sales growth rate by 2% and Ecolab’s organic sales growth rate by 1%, beginning one year after closing. Excluding non-cash amortization costs, the transaction is expected to be accretive to adjusted diluted earnings per share in 2028, with the contribution building significantly thereafter. Returns are expected to be significantly above Ecolab’s weighted average cost of capital.
The acquisition will be financed with new transaction debt. As a result, pro forma net debt to adjusted EBITDA is anticipated to be approximately 3x at transaction close, returning to 2x leverage by the end of the second year after closing.
The acquisition is expected to close in the third quarter of 2026, subject to regulatory approvals and other customary closing conditions.
2026 EPS Outlook
Ecolab expects first quarter 2026 adjusted diluted earnings per share in the $1.69 to $1.71 range, rising 13% to 14% compared with adjusted diluted earnings per share of $1.50 a year ago.
For the full-year 2026, excluding the impact of CoolIT, Ecolab continues to expect adjusted diluted earnings per share in the $8.43 to $8.63 range, rising 12% to 15% compared with adjusted diluted earnings per share of $7.53 in 2025.
Ecolab will release its first quarter 2026 results on Tuesday, April 28, 2026.
Webcast Details
Ecolab will host a live webcast to review the CoolIT acquisition announcement on Monday, March 23, 2026, at 8 a.m. Eastern time. The webcast, along with related presentation slides, will be available to the public on Ecolab’s website at www.ecolab.com/investor.
Citi acted as exclusive financial advisor to Ecolab in connection with the transaction and Covington & Burling LLP acted as legal counsel.
About Ecolab
A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science-based solutions, data-driven insights, AI technology and world-class service. This unique combination enables Ecolab to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, Ecolab has $16 billion in annual sales, 48,000 associates and customers in more than 170 countries and 40 industries. The company helps protect one-third of the world’s food production and a quarter of the power generated while delivering innovative solutions across food, healthcare, data centers, microelectronics, life sciences and hospitality. Ecolab’s comprehensive approach protects what’s vital, aiming by 2030 to help protect 2 billion people from infections and enough drinking water for 1 billion people while enhancing business performance.
Ecolab. Protecting What’s Vital.
www.ecolab.com
About CoolIT
CoolIT Systems specializes in scalable liquid cooling solutions for the world’s most demanding high-performance computing environments. Through its broad portfolio of modular direct liquid cooling (DLC) products, CoolIT enables dramatic increases in rack density, component performance and power efficiency across any high-density computing scenario. CoolIT collaborates with the top semiconductor manufacturers and cloud service providers to develop cooling technologies that enable ever greater computing performance and efficiency. Through its Liquid Lab™ R&D centers in Calgary and Taipei, global manufacturing operations in Canada, China, and Vietnam, and on-site support in more than 80 countries, CoolIT serves customers at scale worldwide. Together, CoolIT and its partners are leading the way for widespread adoption of efficient high-density, high-performance computing.
For more information about CoolIT Systems, its products and technology, visit http://www.coolitsystems.com
Cautionary Statements Regarding Forward-Looking Information
This news release contains certain statements relating to future events and our intentions, beliefs, expectations and predictions for the future which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “we believe,” “we expect,” “estimate,” “project,” “may,” “will,” “intend,” “plan,” “believe,” “target,” “forecast” (including the negative or variations thereof) or similar terminology used in connection with any discussion of future plans, actions or events generally identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding market trends, the future performance of CoolIT, impacts of the acquisition of CoolIT, the expected timing of completion of the acquisition, amortization expense, returns, sales growth, adjusted diluted earnings per share and net debt to adjusted EBITDA ratio. These statements are based on the current expectations of management of the company. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this news release. These risks and uncertainties include (i) the risk that the regulatory approvals or clearances required for the acquisition may not be obtained, or that required regulatory approvals may delay the acquisition or result in the imposition of conditions that could have a material adverse effect on either party or cause either party to abandon the acquisition, (ii) the risk that the conditions to the closing of the acquisition may not be satisfied, (iii) the risk that a material adverse change, event or occurrence may affect Ecolab or CoolIT prior to the closing of the acquisition and may delay the acquisition or cause the company to abandon the acquisition, (iv) problems that may arise in successfully integrating the businesses of the company and CoolIT, which may result in the combined business not operating as effectively and efficiently as expected, (v) the possibility that the acquisition may involve unexpected costs, unexpected liabilities or unexpected delays, (vi) the risk that the credit ratings of Ecolab may be different from what Ecolab currently expects, (vii) the risk that the businesses of Ecolab or CoolIT may suffer as a result of uncertainty surrounding the acquisition, (viii) unexpected operating risks at CoolIT and (ix) the risk that disruptions from the transaction will harm relationships with customers, employees and suppliers.
Other unknown or unpredictable factors could also have material adverse effects on future results, performance or achievements of the company, CoolIT and the combined business. For a further discussion of these and other risks and uncertainties applicable to Ecolab, see Item 1A of our most recent Form 10-K, and our other public filings with the Securities and Exchange Commission. In light of these risks, uncertainties, assumptions and factors, the forward-looking events discussed in this news release may not occur. We caution that undue reliance should not be placed on forward-looking statements, which speak only as of the date made. Ecolab does not undertake, and expressly disclaims, any duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations, except as required by law.
Non-GAAP Financial Information
This news release includes financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (“GAAP”), including organic sales, adjusted diluted earnings per share and adjusted EBITDA. We provide these measures as additional information regarding our operating results. We use these non-GAAP measures internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive compensation. We believe that our presentation of these measures provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results.
Our non-GAAP financial measures for organic sales are at fixed currency and exclude the results of our acquired businesses from the first 12 months post acquisition and the results of divested businesses from the 12 months prior to divestiture. Our non-GAAP financial measures for adjusted diluted earnings per share exclude the impact of special (gains) and charges and discrete tax items. We include items within special (gains) and charges and discrete tax items that we believe can significantly affect the period-over-period assessment of operating results and not necessarily reflect costs and/or income associated with historical trends and future results. EBITDA is defined as net income including non-controlling interest with the sum of provision for income taxes, net interest expense, depreciation and amortization added back. Adjusted EBITDA further adds special (gains) and charges impacting EBITDA. EBITDA and adjusted EBITDA are used in our net debt to adjusted EBITDA ratio, which we view as important indicators of the operational and financial health of our organization.
These non-GAAP financial measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend that investors view these measures in conjunction with the GAAP measures included in this news release.
We do not provide reconciliations for non-GAAP estimates on a forward-looking basis (including those contained in this news release) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of various items that have not yet occurred, are out of our control and/or cannot be reasonably predicted, and that would impact reported earnings per share and the reported net income, the most directly comparable forward-looking GAAP financial measures to adjusted diluted earnings per share and adjusted EBITDA. For the same reasons, we are unable to address the probable significance of the unavailable information.
(ECL-A)
View source version on businesswire.com: https://www.businesswire.com/news/home/20260319353197/en/
Investor Contact:
Andrew C. Hedberg
651-250-2185
Media Contact:
Ecolab Media Relations
651-250-4724
mediarelations@ecolab.com
Original: Ecolab to Acquire CoolIT Systems, a Global Leader in Advanced Liquid Cooling for Next-Gen AI Data Centers
US Market News
3月前
Ecolab Named One of the World’s Most Ethical Companies for 20th Consecutive YearMarch 18, 2026 6:00 AM
Business Wire
Ecolab is just one of six organizations recognized each year since the award’s inception
Ecolab Inc., a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life, today announced it has been named one of the 2026 World’s Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. This marks Ecolab’s 20th consecutive year receiving the recognition—an achievement only a small number of companies worldwide can claim.
“At Ecolab, strong performance starts and ends with doing what’s right,” said Christophe Beck, Chairman and CEO, Ecolab. “For 20 years, this recognition has reflected how our teams lead with integrity, earn trust and deliver results as promised for customers and communities around the world. Winning the right way isn’t just who we are. It's how we perform.”
The World’s Most Ethical Companies assessment is grounded in Ethisphere’s proprietary Ethics Quotient®, which evaluates companies across more than 240 proof points that support robust ethics and compliance programs, including governance, culture, environmental and social impact, and risk management practices. The process also includes extensive qualitative analysis by a panel of experts to identify organizations that demonstrate best-in-class ethics and compliance practices.
Ecolab’s two-decade inclusion on the list reflects the company’s long-standing commitment to delivering its promise with integrity and fostering a culture where associates are encouraged to speak up, act responsibly and look out for one another. Guided by its Code of Conduct and supported by clear ethics resources, Ecolab emphasizes shared ownership of ethics, inclusion and safety across its more than 48,000 associates worldwide, foundational to the company’s track record of high performance and impact.
Ecolab’s ethical leadership is reinforced by a long track record of consistent performance and purpose-led action. The company has been named one of Fortune’s World’s Most Admired Companies, reflecting strength across key reputation drivers including innovation, social responsibility and quality of management. Ecolab also recently earned a double ‘A’ rating from CDP for leadership in water and climate performance, placing the company among the top-performing organizations globally for transparency and environmental impact.
For the full list of companies on Ethisphere’s World’s Most Ethical Companies List, visit: https://worldsmostethicalcompanies.com/honorees.
About Ecolab
A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science-based solutions, data-driven insights, AI technology and world-class service. This unique combination enables Ecolab to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, Ecolab has $16 billion in annual sales, 48,000 associates and customers in more than 170 countries and 40 industries. The company helps protect one-third of the world’s food production and a quarter of the power generated while delivering innovative solutions across food, healthcare, data centers, microelectronics, life sciences and hospitality. Ecolab’s comprehensive approach protects what’s vital, aiming by 2030 to help protect 2 billion people from infections and enough drinking water for 1 billion people while enhancing business performance.
www.ecolab.com
Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.
(ECL-C)
View source version on businesswire.com: https://www.businesswire.com/news/home/20260318792819/en/
Kyle Kapustka
651-250-4724
MediaRelations@Ecolab.com
Original: Ecolab Named One of the World’s Most Ethical Companies for 20th Consecutive Year
US Market News
3月前
Ecolab Appoints Darrell Brown as Co-COO, Global Markets and Greg Cook as Co-COO, Global BusinessesFebruary 25, 2026 4:30 PM
Business Wire
Ecolab Inc. has announced that to support its next phase of growth, it is dividing the chief operating officer role into two complementary positions to build high-performing global businesses while strengthening the foundations for growth in all our markets around the world. As part of these changes, Darrell R. Brown has been appointed Co-COO, Global Markets, and Greg B. Cook has been appointed Co-COO, Global Businesses, effective April 1.
“We ended 2025 with strong momentum, and with that we are increasing our focus and leadership intensity to continue driving strong performance,” said Christophe Beck, Ecolab chairman and chief executive officer. “Darrell has been an exceptional partner and leader over many years. He brings deep company knowledge, a commitment to talent and a winning track record of performance across our global markets. As he returns home to Australia to be closer to family after nearly 15 years abroad, I’m pleased he will continue to serve in this new capacity and contribute to Ecolab’s ongoing success.”
Brown, 62, has served as president and chief operating officer since 2022. Previously, he was executive vice president and president of the Global Industrial Group and earlier led Ecolab’s Energy Services Division. Darrell joined Ecolab in 2002 and has held several international leadership roles.
Cook, 57, joined Ecolab in 1997 and most recently served as executive vice president and president of Ecolab’s Institutional Group. Previously, he was executive vice president and general manager of Global Institutional and has held key international and enterprise leadership roles, including president of the Latin America Region and senior vice president and general manager of Global Pest Elimination.
“Greg has been a trusted partner and proven enterprise leader with a deep understanding of our businesses and customers,” Beck said. “His collaborative leadership style and disciplined execution will provide strong continuity and focus as he leads our Global Businesses. Together, Greg and Darrell will partner to unlock Ecolab’s significant growth opportunities by driving exceptional value for customers around the world.”
About Ecolab
A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science-based solutions, data-driven insights, AI technology and world-class service. This unique combination enables Ecolab to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, Ecolab has $16 billion in annual sales, 48,000 associates and customers in more than 170 countries and 40 industries. The company helps protect one-third of the world’s food production and a quarter of the power generated while delivering innovative solutions across food, healthcare, data centers, microelectronics, life sciences and hospitality. Ecolab’s comprehensive approach protects what’s vital, aiming by 2030 to help protect 2 billion people from infections and enough drinking water for 1 billion people while enhancing business performance.
www.ecolab.com
Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.
(ECL-C)
View source version on businesswire.com: https://www.businesswire.com/news/home/20260225386670/en/
Investor Contact:
Andrew Hedberg
651-250-2185
Media Contact:
Torry Whitney
651-250-4724
MediaRelations@Ecolab.com
Original: Ecolab Appoints Darrell Brown as Co-COO, Global Markets and Greg Cook as Co-COO, Global Businesses
iHub News
4月前
Ecolab edges past fourth-quarter estimates on margin strength, outlook meets expectationsFebruary 10, 2026 11:18 AM
IH Market News
Ecolab (NYSE:ECL) posted fourth-quarter results that came in just ahead of expectations, supported by improved margins and steady sales growth, while its profit outlook for 2026 largely matched Wall Street forecasts. Shares slipped 0.22% in premarket trading following the release.Adjusted earnings per share totaled $2.08 for the quarter, topping the consensus estimate of $2.07 by a penny. Revenue reached $4.19 billion, in line with analyst projections. Sales increased 5% year over year, with organic sales up 3%, driven primarily by stronger performance in Food & Beverage, Pest Elimination, Life Sciences, Specialty, and Global High-Tech.The company said these gains helped offset a combined 2% headwind from softer conditions in basic industries, paper, and reduced distributor inventories within its Institutional segment.Operating income margin came in at 17.0%, while organic operating income margin expanded by 140 basis points to 18.5%. Reported diluted EPS was $1.98, representing a 19% increase, and adjusted diluted EPS rose 15% from the prior year.Looking ahead to 2026, Ecolab expects adjusted EPS in a range of $8.43 to $8.63, compared with the analyst consensus of $8.48. The forecast includes an approximate $0.13 per-share impact from non-cash amortization related to the Ovivo Electronics acquisition. For the first quarter, the company anticipates adjusted EPS of $1.67 to $1.73, reflecting growth of 11% to 15%.Chief Executive Christophe Beck said Ecolab delivered record sales, margins, and cash flow in 2025, with performance fueled by organic sales growth and margin expansion.He added that inventory pressures in the Institutional segment are expected to largely normalize in the first quarter of 2026, while weakness in basic industries and paper should ease over the coming quarters.For the full year, Ecolab projects reported sales growth of 7% to 9% in 2026, with organic sales rising 3% to 4% and operating income margin expanding by 100 to 150 basis points. The company also raised its expected annual productivity-related savings target to $325 million by 2027.Ecolab stock price
Original: Ecolab edges past fourth-quarter estimates on margin strength, outlook meets expectations